MA of Tryptophan in Cornmeal in Healthy Adults>60y

NCT ID: NCT07272668

Last Updated: 2025-12-09

Basic Information

• Recruitment Status: ENROLLING_BY_INVITATION
• Clinical Phase: NA
• Total Enrollment: 40 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2025-11-29
• Study Completion Date: 2026-05-02

Brief Summary

The world's population will reach 12 billion by this century's end. As the human population increases, the world faces the continuous challenge of optimizing a limited food supply. Protein is the key determinant of growth and bodily function. Recently, our group showed that current protein recommendations for adults and children are underestimated by 30-50%. Animal protein production is "more resource intensive than any other form of food production" and their high saturated fat content is linked to chronic diseases in developed nations. Plant protein sources are important alternatives shown to "enhance ecosystem resilience and improve human health". Maize, commonly known as corn, is a staple food in the diets of more than 300 million Africans and ranks as the third most produced food globally. Maize supplies up to 80% of daily energy in sub-Saharan and Southern Africa alone. It is one of the main protein sources in these countries for vegetarians. Already, over 900,000 Canadians adults are vegetarians and globally plant protein consumption is encouraged. However, maize protein is limiting in the essential amino acid (EAA) tryptophan and anti-nutritional factors can affect tryptophan bioavailability (BA). Dietary protein quality (DPQ) depends on its amino acid (AA) composition and BA. Therefore, knowledge of tryptophan BA is fundamental to understand the extent to which cereal grains meet the body's requirement for protein synthesis (PS). Efforts aimed at increasing crop production and DPQ, should coincide with DPQ evaluation directly in humans so that the gap in knowledge between protein requirement and how best to provide it can be quickly and efficiently reconciled.

Detailed Description

Protein quality evaluation assesses the capacity of food proteins to meet the EAA needs of the body. The DPQ of plant proteins have been little studied in humans despite their importance in the diet and their well-recognized positive effects on chronic diseases. Dietary guidelines are encouraging increased plant protein consumption due to the benefits of plant protein. With the increasing interest in vegetarian diets in North America, it is imperative that the DPQ of cereal grains be evaluated so that plant protein recommendations are accompanied by an empirical understanding of plant protein quality. The information gathered from this project will provide additional experimental data in humans on plant protein quality (have completed lentils and chickpeas), on which nutrition recommendations can be built. Globally, this will also help support the FAO's commitment to compile tables on AABA of foods for global distribution. The aim of the study is to apply the IAAO method to determine the MA of tryptophan in maize prepared by moist cooking method.

Conditions

Protein Absorption and Amino Acid Availability

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: BASIC_SCIENCE
• Blinding Strategy: NONE

Study Groups

MA of tryptophan in maize

Apply the IAAO method to determine the metabolic availability of tryptophan in maize prepared by moist cooking method

Group Type: EXPERIMENTAL

Tryptophan

Intervention Type: OTHER

4 different tryptophan test levels 0.5, 1, 1.5 and 2 mg.kg-1.day.1

Interventions

Tryptophan

4 different tryptophan test levels 0.5, 1, 1.5 and 2 mg.kg-1.day.1

Intervention Type: OTHER

Other Intervention Names

maize

Eligibility Criteria

Inclusion Criteria

• Aged 60 to 90 years old.
• In good general health as evidenced by medical history, physical health and blood draw.
• Fasting blood glucose, hemoglobin A1c (HbA1c), urea, creatinine.
• Willingness to participate in the study.
• BMI <30 kg/m2.

Exclusion Criteria

• Presence of chronic disease and/or acute illness known to affect protein/amino acid metabolism (e.g. HIV, diabetes, taking medications known to affect protein/AA metabolism (e.g. steroids).

• Inability to tolerate the diet (i.e. allergy).
• Significant weight loss during the past month or consumption of weight reducing diets.
• Significant caffeine consumption (>2 cups per day).
• Significant consumption of alcohol (>1 drink per day i.e. 1 beer or ½ glass of wine).
• Unwilling to have blood drawn from a venous access or using a ventilated hood indirect calorimeter for the purposes of the study.

• Minimum Eligible Age: 60 Years
• Maximum Eligible Age: 90 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

The Hospital for Sick Children

OTHER

Sponsor Role: lead

Responsible Party

Glenda Courtney-Martin

Associate Scientist

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Glenda Courtney Martin, PhD, RD

Role: PRINCIPAL_INVESTIGATOR

The Hospital for Sick Children

Locations

The Hospital for Sick Children

Toronto, Ontario, Canada

Countries

Canada

Other Identifiers

3568

Identifier Type: -

Identifier Source: org_study_id